269 related articles for article (PubMed ID: 15683610)
1. Targeting immunoglobulin E as a novel treatment for asthma.
Sandström T
Curr Allergy Asthma Rep; 2005 Mar; 5(2):109-15. PubMed ID: 15683610
[TBL] [Abstract][Full Text] [Related]
2. What is new in antiimmunoglobulin E asthma therapy.
Berger WE
Allergy Asthma Proc; 2005; 26(6):428-34. PubMed ID: 16541964
[TBL] [Abstract][Full Text] [Related]
3. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
Holgate ST; Djukanović R; Casale T; Bousquet J
Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
[TBL] [Abstract][Full Text] [Related]
4. Omalizumab and the treatment of allergic rhinitis.
Kaliner MA
Curr Allergy Asthma Rep; 2004 May; 4(3):237-44. PubMed ID: 15056407
[TBL] [Abstract][Full Text] [Related]
5. Omalizumab: a monoclonal anti-IgE antibody.
Belliveau PP
MedGenMed; 2005 Jan; 7(1):27. PubMed ID: 16369332
[TBL] [Abstract][Full Text] [Related]
6. Omalizumab in asthma: approval and postapproval experience.
Chiang DT; Clark J; Casale TB
Clin Rev Allergy Immunol; 2005 Aug; 29(1):3-16. PubMed ID: 16222080
[TBL] [Abstract][Full Text] [Related]
7. Anti-IgE antibodies for the treatment of asthma.
Buhl R
Curr Opin Pulm Med; 2005 Jan; 11(1):27-34. PubMed ID: 15591885
[TBL] [Abstract][Full Text] [Related]
8. A recombinant humanized anti-IgE monoclonal antibody (omalizumab) in the therapy of moderate-to-severe allergic asthma.
D'Amato G; Piccolo A; Salzillo A; Noschese P; D'Amato M; Liccardi G
Recent Pat Inflamm Allergy Drug Discov; 2007 Nov; 1(3):225-31. PubMed ID: 19075985
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR.
Vignola AM; Humbert M; Bousquet J; Boulet LP; Hedgecock S; Blogg M; Fox H; Surrey K
Allergy; 2004 Jul; 59(7):709-17. PubMed ID: 15180757
[TBL] [Abstract][Full Text] [Related]
10. Omalizumab: an effective anti-IgE treatment for allergic asthma and rhinitis.
Casale TB;
Drugs Today (Barc); 2004 Apr; 40(4):367-76. PubMed ID: 15190389
[TBL] [Abstract][Full Text] [Related]
11. Omalizumab: anti-IgE monoclonal antibody E25, E25, humanised anti-IgE MAb, IGE 025, monoclonal antibody E25, Olizumab, Xolair, rhuMAb-E25.
BioDrugs; 2002; 16(5):380-6. PubMed ID: 12408744
[TBL] [Abstract][Full Text] [Related]
12. Treatment of allergic rhinitis and other immunoglobulin E-mediated diseases with anti-immunoglobulin E antibody.
Berger WE
Allergy Asthma Proc; 2006; 27(2 Suppl 1):S29-32. PubMed ID: 16722329
[TBL] [Abstract][Full Text] [Related]
13. Etiopathogenesis and management of perennial allergic rhinitis: a state-of-the-art review.
Bush RK
Treat Respir Med; 2004; 3(1):45-57. PubMed ID: 15174893
[TBL] [Abstract][Full Text] [Related]
14. Omalizumab : other indications and unanswered questions.
Mankad VS; Burks AW
Clin Rev Allergy Immunol; 2005 Aug; 29(1):17-30. PubMed ID: 16222081
[TBL] [Abstract][Full Text] [Related]
15. [Omalizumab, recombinant humanized monoclonal antibody anti-IgE -- new fields of studies on the therapeutic indications].
Kupryś-Lipińska I; Kuna P
Pneumonol Alergol Pol; 2009; 77(1):43-51. PubMed ID: 19308909
[TBL] [Abstract][Full Text] [Related]
16. Anti-IgE monoclonal antibody (omalizumab) in the treatment of atopic asthma and allergic respiratory diseases.
D'Amato G; Liccardi G; Noschese P; Salzillo A; D'Amato M; Cazzola M
Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):227-9. PubMed ID: 15379589
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal anti-IgE antibody: a novel therapy for allergic airways disease.
Berger WE
Ann Allergy Asthma Immunol; 2002 Feb; 88(2):152-60; quiz 161-2, 208. PubMed ID: 11868919
[TBL] [Abstract][Full Text] [Related]
18. Anti-IgE therapy: clinical utility beyond asthma.
Casale TB; Stokes J
J Allergy Clin Immunol; 2009 Apr; 123(4):770-1.e1. PubMed ID: 19348915
[No Abstract] [Full Text] [Related]
19. [Anti-IgE (Omalizumab): a hope in the treatment of allergic diseases].
Félix Toledo R; Negro Alvarez JM
Rev Clin Esp; 2003 Apr; 203(4):196-8. PubMed ID: 12681204
[No Abstract] [Full Text] [Related]
20. Omalizumab. A review of the new treatment of allergic asthma and seasonal allergic rhinitis.
Félix Toledo R; Negro Alvarez JM; Miralles López JC
Allergol Immunopathol (Madr); 2002; 30(2):94-9. PubMed ID: 11958741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
